The new list from EvaluatePharma on the top 20 late-stage drugs in the pipeline — included in its big annual report on the industry — underscores just how hard that is, and also how much progress AbbVie is making.Read more
One more difficult year for Ukraine has already passed. Slowly, but inevitably Ukraine is moving towards better times. Certain signs of recovery are already visible but still are far away. We are witnessing qualitative changes of the Ukrainian Healthcare sector and robust changes of rules for all industry stakeholders. This issue we have devoted to the results of 2016 FY. As always, only the most important, briefly and in a new design - Upharmacia - 2016: Year Results.Read more
Dear colleagues, partners, and friends, please, check out our recent digest of the key news and events in the sphere of the Ukrainian pharmaceutical business for December 2016.Read more
We are proudly presenting you our new issue of Kazakhstan Pharmaceutical Industry Overview 2016. The Overview will guide you through the Kazakh current economics situation, pharmaceutical market structure and trends, leading local pharmaceutical manufacturers and the latest regulatory changes in the pharmaceutical marketing sphere.